We demonstrated that IFNA17 overexpression might enhance functional characteristics, such as migration, proliferation, and association with elevated levels of CHRM4, NE markers, and immune checkpoints in prostate cancer cells. The gene discussed is CHRM4; the disease is prostate carcinoma.